Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank100
3Y CAGR+51.5%
Studio
Year-over-Year Change

Return on invested capital

3Y CAGR
+51.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
20258.17%+186.3%
2024-9.47%-306.5%
20234.58%+95.1%
20222.35%+102.9%
2021-81.86%-66.3%
2020-49.22%+33.0%
2019-73.48%-90.2%
2018-38.63%+82.2%
2017-217.55%-390.9%
2016-44.31%-